Abstract. Cytoplasmic dynein is a retrograde microtubule motor thought to participate in organelle transport and some aspects of minus end-directed chromosome movement. The mechanism of binding to organelles and kinetochores is unknown. Based on homology with the Chlamydomonas flagellar outer arm dynein intermediate chains (ICs), we proposed a role for the cytoplasmic dynein ICs in linking the motor protein to organelles and kinetochores. In this study two different IC isoforms were used in blot overlay and immunoprecipitation assays to identify IC-binding partners. In overlays of complex protein samples, the ICs bound specifically to polypeptides of 150 and 135 kD, identified as the p150 Glued doublet of the dynactin complex. In reciprocal overlay assays, p150 Gluea specifically recognized the ICs. Immunoprecipitations from total Rat2 cell extracts, rat brain cytosol, and rat brain membranes further identified the dynactin complex as a specific target for IC binding. Using truncation mutants, the sites of interaction were mapped to amino acids 1-123 of IC-1A and amino acids 200-811of p150 cl"ea. While cytoplasmic dynein and dynactin have been implicated in a common pathway by genetic analysis, our findings identify a direct interaction between two specific component polypeptides and support a role for dynactin as a dynein "receptor". Our data also suggest, however, that this interaction must be highly regulated.
bule motor thought to participate in organelle transport and some aspects of minus end-directed chromosome movement. The mechanism of binding to organelles and kinetochores is unknown. Based on homology with the Chlamydomonas flagellar outer arm dynein intermediate chains (ICs), we proposed a role for the cytoplasmic dynein ICs in linking the motor protein to organelles and kinetochores. In this study two different IC isoforms were used in blot overlay and immunoprecipitation assays to identify IC-binding partners. In overlays of complex protein samples, the ICs bound specifically to polypeptides of 150 and 135 kD, identified as the p150 Glued doublet of the dynactin complex. In reciprocal overlay assays, p150 Gluea specifically recognized the ICs. Immunoprecipitations from total Rat2 cell extracts, rat brain cytosol, and rat brain membranes further identified the dynactin complex as a specific target for IC binding. Using truncation mutants, the sites of interaction were mapped to amino acids 1-123 of IC-1A and amino acids 200-811of p150 cl"ea. While cytoplasmic dynein and dynactin have been implicated in a common pathway by genetic analysis, our findings identify a direct interaction between two specific component polypeptides and support a role for dynactin as a dynein "receptor". Our data also suggest, however, that this interaction must be highly regulated.
C
YTOPLASMIC dynein is a minus end-directed microtubule motor thought to participate in retrograde axonal transport, centripetal organelle movement, and some aspects of chromosome segregation (for a review see Holzbaur and Vallee, 1994) . It has been found to be associated with a variety of membranous organelles including endocytic vesicles (Lin and Collins, 1992; Aniento et al., 1993) , lysosomes (Lin and Collins, 1992) , and components of the Golgi apparatus (Corthezy-Theulaz et al., 1992; Fath et al., 1994) . Cytoplasmic dynein has also been implicated in the formation of endoplasmic reticulum networks in Xenopus interphase extracts (Allan, 1995) , and has been found to bind to microsomes in vitro (Yu et al., 1992) . Cytoplasmic dynein may also function in minus end-directed chromosome movement. Antibodies to subunits of the complex have been found to label kinetochores during mitosis (Pfarr et al., 1990; Steuer et al., 1990) . Furthermore, analysis of chromosome movement in vitro (Hyman and Mitchison, 1991) and in vivo (Rieder and Alexander, 1990) has suggested a role for cytoplasmic dynein in this process during prometaphase. Additional roles for cytoplasmic dynein in ogy with the product of the Glued gene in Drosophila (Holzbaur et al., 1991; Gill et al., 1991) ; Arpl, a novel actin-related protein (Lees-Miller et al., 1992; Paschal et al., 1993) ; p50 (Paschal et al., 1993; Echeverri et al., 1996) ; actin-capping protein (Schafer et al., 1994) ; and several uncharacterized subunits. Like cytoplasmic dynein, dynactin localizes to small, punctate, detergent-extractable structures distributed throughout the cytoplasm (Gill et al., 1991; Clark and Meyer, 1992; Paschal et al., 1993) . During mitosis, the two complexes have recently been found to colocalize to kinetochores (Echeverri et al., 1996) . Dynein and dynactin have also been deduced to function in a common pathway by genetic analysis in Saccharornyces cerevisiae (Eshel et al., 1993; Li et a1.,1993; Muhua et a1.,1994) , Neurospora crassa (Plamann et al., 1994) , Aspergillus nidulans (Xiang et al., 1994) , and Drosophila rnelanogaster (McGrail et al., 1995) . Furthermore, the two complexes substantially copurify through microtubule sedimentation, ATP extraction, and sucrose density gradient sedimentation (Collins and Vallee, 1989; Schroer and Sheetz, 1991; Gill et al., 1991; Paschal et al., 1993) , though they can largely be separated by ion-exchange chromatography Gill et al., 1991) . Substantial coimmunoprecipitation from cytosolic extracts was not observed using antisera to the ICs or p50 (Paschal et al., 1993; .
This study was initiated as a search for cytoplasmic dynein receptors, based on the premise that the ICs should mediate interactions between cytoplasmic dynein and the surface of organelles and kinetochores. We report that a previously cloned and a novel IC isoform both interact with the p150 Gtued component of the dynactin complex.
These data represent the first evidence for a direct interaction between dynein and dynactin. In addition, in view of the known properties of p150 trued, they suggest that the interaction of cytoplasmic dynein with its subcellular targets is likely to be complex.
Materials and Methods

Intermediate Chain cDNA Cloning
Screening for additional IC cDNAs was performed by RT-PCR using primers in the 5'-end of the coding sequence (cf. Paschal et al., 1992) and by DNA hybridization to a k-ZAPII rat brain cDNA library (Stratagene, La Jolla,CA) using a divergent human cytoplasmic dynein IC cDNA for which limited sequences had been reported. 26 novel cDNAs were identified by the latter method and were characterized after three rounds of plaque purification and excision by helper phage. Individual clones were end-sequenced and the longest representative of each of three splicing variants was sequenced to completion using a combination of convenient restriction sites and custom oligonucleotides.
cDNA fragments representing the 3' untranslated regions of IC-1 (562 bp) and IC-2 (553 bp) were isolated by restriction digestion, agarose gel electrophoresis, and gel purification. These fragments were used as hybridization probes after random priming and removal of unincorporated nucleotides by spin-column chromatography (Boehringer-Mannheim, Indianapolis, IN). A rat multi-tissue Northern blot (MTN, Clontech Laboratories, Palo Alto, CA) was probed with both the IC-l-specific and IC-2-specific probes using Rapid-Hyb (Amersham Corp., Arlington Heights, IL), at 58°C, followed by high stringency washing in 0.2 X SSPE (2 mM NaPO4, pH 7.0, 36 mM NaC1, 0.2 mM sodium EDTA) at 60°C.
Sequence Analysis
Coiled-coiled domains were identified using the NEWCOILS program (Lupas et al., 1991) . Sequence assembly, comparisons, and alignments were performed using the GELASSEMBLE, COMPARE, and PILEUP programs of GCG (GCG sequence analysis package). Statistical significance of comparisons was assessed using RDF2 (Lipman and Pearson, 1988) .
Expression of lC Isoforms in E. coli
The coding regions of 1C-1A and IC-2B were subcloned into the pET-14b expression vector (Novagene, Madison, WI) after PCR mutagenesis and standard cloning techniques. After transformation into the expression strain BL21(DE3) and induction with 0.4 mM IPTG, bacteria were lysed using a French press and expressed proteins were purified using nickelaffinity chromatography. The NH2-terminal his-finger was removed by thrombin cleavage followed by dialysis, and cleavage was confirmed by SDS-PAGE. A c-myc epitope-tag was added by introducing a Ncol restriction site in place of the termination codons of IC-1A and IC-2B by PCR mutagenesis followed by subcloning into a pBluescript vector containing the myc epitope-encoding sequence.
Truncation mutants were prepared in pET-14b using internal restriction sites in the IC-1A cDNA as well as PCR mutagenesis. Expressed polypeptides were purified as described above, p150 ~;'ea truncation mutants expressing residues 39-1325, 150-811, and 811-1325 have been previously described (Waterman-Storer et al., 1995) . An NH2-terminal p150 cl"ed mutant containing residues 1-200 was prepared by PCR and standard cloning techniques.
Preparation of Antisera
Antibody against IC-1 was prepared by immunizing New Zealand White rabbits with the purified recombinant IC-1A polypeptide and was affinitypurified against the same polypeptide. An IC-2 antiserum was prepared against the COOH-terminal 19 residues of the IC-2 protein (Research Genetics, Huntington, AL). A previously described p150 Gtued antibody was used for immunoblotting (Waterman-Storer et al., 1995) . For immunoprecipitation a rabbit polyclonal antiserum was generated against the NH2-terminal 200 amino acids of p150 ch'ed, and shown to bind p150 c;ued specifically in both immunoblotting (not shown) and immunoprecipitation assays (see Fig. 9 A) . Hybridomas producing monoclonal antibodies to c-myc were obtained from Amer. Type Culture Collection (Rockville, MD) (Evan et al., 1985) . Polyclonal anti-myc antiserum was generously provided by Melissa Gee.
Blot Overlay Assays
Protein samples were fractionated by SDS-PAGE and transferred to PVDF (polyvinylidene difluoride) membranes electrophoretically. After overnight incubation at 4°C in PBS (8 mM NaPO4, 1 mM KPO4, pH 7.4 containing 140 mM NaCl and 3 mM KCI) containing 0.05 % Tween-20 and 6% nonfat dry milk, the membrane strips were incubated in PBS/Tween-20/milk containing the recombinant protein probe for I h at room temperature. Binding in the overlay assay improved with extended preincubation of the membrane strips in PBS/Tween-20/milk at 4°C. Recombinant ICs with an intact HIS-tag did not work in our assay. Reaction intensity was dependent on recombinant protein concentration over the range of 0.1 t~g/ml to 10 ~g/ml and concentrations from 0.1 g.g/ml to i ixg/ml were typically used to minimize background. To visualize the recombinant protein, strips were washed 4 x 15 rain in PBS/Tween-20, incubated with primary antibody in PBS/Tween-20/milk for 1 h at room temperature, washed 4 × 15 min in PBS/Tween-20, incubated in secondary antisera (HRP-conjugated donkey anti-mouse, Jackson Immunoresearch, West Chester, PA; HRP-conjugated goat anti-rabbit, Pierce, Rockford, IL), and processed for ECL (Amersham Corp.).
Immunoprecipitation
Rat brain cytosol was prepared as described (Paschal et al., 1993) . The crude membrane pellet fraction recovered from 150,000 g centrifugation of the postnuclear supernatant was washed five times in PEM buffer and solublized in 1% NP--40. Goat anti-rabbit agarose beads (American Qualex, LaMirada, CA) were preloaded with rabbit anti-IC antibody or rabbit anti-myc antiserum plus the appropriate recombinant IC. Immunoprecipitates were analyzed by immunoblotting. Blots were probed with rabbit antibodies recognizing p150 Gtued (Waterman-Storer et al., 1995) , a mouse monoclonal antibody against p50 (Paschal et al., 1993 ) and a mouse mono-clonal antibody against Arp-1 (Clark, S., and D. Meyer, personal communication) by standard methods.
Alternatively, subeonfluent Rat2 cells grown in DMEM containing 10% FCS were incubated in Met/Cys-deficient DMEM containing 5% dialyzed FCS for 1 h. Cells were labeled in Met/Cys-deficient DMEM containing 5% dialyzed FCS and 80 ixCi/ml Tran 35 SLabel (ICN Biomedicals, Costa Mesa, CA) for 4 h, and chased for 1 h in normal DMEM containing 10% FCS. Cells were scraped into RIPA buffer (50 mM Tris-HC1, pH 8.0, 150 mM NaCI, 1% NP--40, 0.05% Tween-20, 100 p,g/ml PMSF, 1 ixg/ml leupeptin, 10 i~g/ml TPCK, 10 p,g/ml TAME, 1 ixg/ml aprotinin, 1 ~g/ml pepstatin A), followed by 10 passes in a tight fitting Dounce homogenizer. The extract was centrifuged at 3,000 g for 20 min at 4°C, followed by 150,000 g for 1 h at 4°C, preadsorbed against Protein A-Sepharose beads (Pharmacia, Piscataway, NJ), incubated with immune beads overnight at 4°C, and eluted with 4% acetic acid. Samples were subjected to SDS-PAGE, and the gel was incubated in Enlightening (Dupont, New England Nuclear, Boston, MA) and analyzed by autoradiography.
Results
Cytoplasmic Dynein Intermediate Chain lsoform Complexity
The ICs of purified cytoplasmic dynein migrate by 1-D (Paschal et al., , 1992 and 2-D gel electrophoresis (Dillman and Pfister, 1994) as a heterogeneous group of bands of approximately 74 kD. As a first step in our attempt to identify IC-binding partners, we sought to resolve to what extent the observed electrophoretic complexity reflects isoform diversity. RT-PCR analysis of rat brain mRNA had revealed the existence of an apparent alternative splicing site near the 5'-end of the IC sequence (Paschal et al., 1992) . In addition, homologous but partially divergent amino acid sequence was obtained from a bovine tryptic peptide from the same region of the molecule, suggesting further polypeptide diversity.
Further PCR based screening of rat brain mRNA failed to reveal additional IC isoforms. However, a report of limited sequence from two partial cDNA clones supported the possibility of further mRNA complexity (Adams et al., 1993a, b) . Complete sequencing of human clone EST 04626 revealed 1,058 bp of IC-related coding sequence, exhibiting 75 % identity to our previously reported IC, and corresponding to an internal fragment from aa 76 to 456. Because this sequence contained the divergent sequence observed in our bovine peptide fragment (see above; Paschal et al., 1992) , we speculated that the human cDNA might encode a novel IC isoform. To evaluate this possibility, we probed a rat brain cDNA library using the human clone and selected 26 additional IC cDNAs. These clones were distinct in sequence from that of the initially cloned rat cytoplasmic dynein IC (Paschal et al., 1992) . They exhibited extensive regions of amino acid sequence identity with our initial IC clone, and showed two regions of variability near the 5'-end of the coding sequence (Fig. 1, A and B). Seven of sixteen peptide fragments sequenced for the initial IC cloning (Paschal et al., 1992; and unpublished data) appear to have been derived from this new IC polypeptide.
Together, the sequence data suggest the existence of two IC genes, which we term IC-1 and IC-2, each encoding multiple isoforms as the result of a probable alternative splicing mechanism. The existence of two genes is supported by genomic mapping data, which place IC-1 and IC-2 at distinct loci within the mouse genome (K. T. N. G. Copeland, N. A. Jenkins, and R. B. Vallee. 1995 . Identification of multiple genomic loci involved in dyneinbased motility. Mol. Biol. Cell 6:154a). Apparent alternative splicing occurs at at least two sites within IC-2. The second site is at the same position as a comparable site of alternative splicing in IC-1, and the alternate sequence at this site is closely related between IC-1 and IC-2 (Fig. 1 b) . Overall sequence identity between IC-1 and IC-2 is highest within the COOH-terminal half, but regions of identity were also observed in the NH2-terminal half. This consistent pattern among all known cytoplasmic and axonemal ICs (Paschal et al., 1992; Mitchell and Kang, 1991; Wilkerson et al., 1995) suggests a common function associated with the COOH-terminal half, such as binding to the dynein HCs, and distinct functions associated with the NH2-terminal half. Pairwise comparisons show that each of the rat brain ICs is more closely related to the IC78 of Chlamydomonas flagellar dynein than to IC70 (data not shown). Common structural features of the rat cytoplasmic dynein ICs (Fig. 1 C) are an NH2-terminal predicted coiled-coil domain including a region rich in amino acids of mixed charge, and a serine-rich cluster comparable to a putative site of phosphorylation in CLIP-170 (Pierre et al., 1992) . Phosphorylation in this region of CLIP-170 has been implicated in the regulation of microtubule binding (Rickard et al., 1990) . Each of the IC isoforms contains a series of "WD" repeats (Neer et al., 1994) , a proposed protein-protein interaction motif also identified in the Chlamydomonas flagellar outer arm dynein ICs (Wilkerson et al., 1995) .
Northern blot analysis using 3'-untranslated region-specific probes indicated differential expression of these two isoform families (Fig. 2) . While the IC-2 specific probe detected mRNAs in each tissue tested, the IC-1 specific probe only hybridized to transcripts expressed in brain. A weak IC-1 hybridization signal was also detected in testis at long exposures (data not shown).
Identification of IC-binding Proteins
To identify proteins that ICs were capable of binding, we expressed NH2-terminal his-tagged IC-1A and IC-2B with and without a COOH-terminal myc-tag, in E. coli. A substantial fraction of the recombinant protein was soluble in each case, and could be purified using nickel-affinity chromatography (Fig. 3) along with a variable level of premature-termination products. Test protein samples were fractionated by SDS-PAGE, electroblotted, and incubated with recombinant ICs, which were visualized using anti-IC or anti-myc antibodies.
In control samples of whole Rat2 cell lysate incubated in anti-IC antibody, endogenous ICs were detected (Fig. 4 A,  lane 3 ). After incubation with recombinant IC-1A, the anti-IC antibody detected an additional prominent doublet at 150 and 135 kD (Fig. 4 A, lane 2) , as well as other minor bands. The protein doublet appeared to comigrate with the p150 ct"ed doublet (Fig. 4, B and C, lane 3) . A comparable pattern of IC reactivity was observed using rat brain cytosol (see below, Fig. 8 A) , bovine brain microtubules (Fig. 4 B) and sucrose density gradient-purified cyto- (Paschal et al., 1992) . The longest representative eDNA of each IC-2 variant is presented. IC-1 and IC-2 exhibit 76% identity overall, with the COOHterminal halves showing 82% identity and the NH2-terminal halves showing 72% identity. The sequences of IC-2A, IC-2B, IC-2C, and the complete sequence of the human cDNA EST04626 can be obtained from Genbank through Accession numbers U39044, U39045, U39046, and U39575. (B) Alignment of cytoplasmic dynein IC family members within NH2-terminal variable region. Gaps were inserted by PILEUP (GCG sequence analysis package) to optimize alignment. The human sequence is 93.5 % identical to the rat IC-2 isoforms and is referred to as hIC-2. (C) Summary of structural features identified through comparison of IC isoforms. The NH2-terminal coiled-coil domain is highly conserved, as is a serine cluster nested between the two regions of alternative sequence. Scale bar represents 100 amino acids.
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plasmic dynein (not shown). Myc-tagged IC-1A followed by anti-myc antibody also showed prominent staining of the 150/135-kD doublet. Staining of endogenous ICs was not observed (Fig. 4 B, lane 2) . Blots were also probed with recombinant/C-2B, which again bound specifically to the 150/135-kD doublet (Fig. 4 C, lane 1) . Similar results were obtained with myc-tagged IC-2B (Fig. 4 C, lane 2) .
Identification of IC-binding Polypeptides as p150 6t''ed
The electrophoretic mobility of the 150/135 kD doublet was reminiscent of that of p150 ct~ed (Holzbaur et al., 1991 p150 Glued for IC reactivity. Because full-length p150 Glued could not be expressed intact, fragments of the protein were used. Recombinant polypeptides consisting of residues 39-1325 and 150-811 showed strong IC-1 and IC-2 reactivity (Fig. 5, A and B, lanes 1 and 2), in contrast to a fragment consisting of residues 811-1325 which was negative in the assay (Fig. 5, A and B, lanes 3). As a further means to assay for IC-p150 ct"ed binding, the aa 150-811 fragment was used to probe blots of total Rat2 cell extract (Fig. 6 A) and bovine brain microtubules (Fig.  6 B) . In control samples incubated in anti-pl50 cl"ed anti- body, only the p150 ah'ed doublet was observed to react, reflecting detection of endogenous p150 aluea (Fig. 6, A and  B, lanes 3 ). After incubation with recombinant p150 ct"ed, a single additional prominent band comigrating with the ICs was observed (Fig. 6, A and B, lanes 1) .
We used a series of truncation mutant constructs in overlays of partially purified microtubules, to gain further insight into the region of p150 az"ed responsible for IC-binding (Fig. 7, Table I ). Truncated forms of p150 ct"ea containing residues 39-1325 (Fig. 7, lane 3) and 150-811 (Fig. 7 , lane 4) bound the ICs, whereas mutants containing residues 811-1325 (Fig. 7, lane 5) and 1-200 (Fig. 7, lane 6) did not. We note that truncation mutants containing residues 39-1325 (Fig. 7, lane 3) and 1-200 (Fig. 7, lane 6 ) also bound tubulin in our assays.
IC-binding Site f o r p150 Gtued
To identify the region of the ICs involved in binding to the p150/135 doublet, a series of truncation mutants of IC-1A were expressed in E. coli and used to probe rat brain cytosol (Fig. 8 A, Table I ). The anti-IC antibody detected endogenous ICs in each case. In addition, reaction was observed with p150 Gtued in lanes incubated with COOH-terminal IC truncation mutant polypeptides as short as 123 amino acids (IC-1A residues 1-123, Fig. 8 A, lane 4) . This portion of the ICs contains the predicted coiled-coil domain, the serine cluster, and the region of apparent alternative splicing. No reaction with p150 trued was observed using a smaller COOHterminal truncation fragment (aa 1-61, Fig. 8 A, lane 5) , or NH2-terminal truncation fragments lacking either the first 61 (Fig. 8 A, lane 6 ) or 123 amino acids (Fig. 8 A, lane 7) .
To confirm the identification of the p150C/ued-binding region, the IC fragments were blotted to PVDF membranes, and probed with a recombinant p150 ct"ed fragment (aa 150-811) (Fig. 8 B, Table I ). Binding was again detected with COOH-terminal truncation fragments as small as aa 1-123 (Fig. 8 B, lane 4) , but was undetectable with the smaller COOH-terminal fragment (aa 1-61, Fig. 8 B, lane 5) and with an NH2-terminal truncation fragment (aa 61-643, Fig. 8 B, lane 6) .
Solution Assays for an IC-Dynactin Interaction
To assess the ability of the ICs to interact with components of the dynactin complex which had not been subjected to denaturing conditions, we performed immunoprecipitations from metabolically labeled cultured Rat2 cells (Fig. 9 A) , or rat brain cytosol and membranes (Fig. 9 , B and C). As observed previously using a monoclonal anti-IC antibody (Paschal et al., 1993) , our polyclonal anti-IC antibodies did not immunoprecipitate dynactin efficiently (Fig. 9 A, lane 2; Fig. 9 , B and C, lanes 2). However, after supplementing extracts with purified ICs, we observed substantial, specific coimmunoprecipitation of the p150 trued, p50, and Arpl components of the dynactin complex (Fig. 9  A, lanes 3 and 5; Fig. 9 , B and C, lanes 3, 5, 7, and 8). Comparable results were obtained using IC-1A (Fig. 9 A, lane 3; Fig. 9 B, lane 3) , IC-1A-myc (Fig. 9 A, lane 5; Fig. 9 B, lane 7), IC-2B (Fig. 9 B, lane 5) , or IC-2B-myc (Fig. 9 B,  lane 8) . Similar levels of p150 trued were observed in immunoprecipitates from rat cytosol and membranes (Fig. 9 C) . In a separate series of experiments, both p150 Glued and p50 were also found to bind to recombinant IC-1A and IC-2B affinity matrices, while no binding was observed using BSA or a control IC construct consisting of IC-1A residues 61-643 (data not shown).
D i s c u s s i o n
Through our search for cytoplasmic dynein-binding partners, we have discovered a direct interaction between the ICs and p150 Glued. These data represent the first compelling evidence for an interaction between cytoplasmic dynein and dynactin, and indicate that binding occurs specifically through the ICs and p150 aJued. In view of the likely role for the ICs in subcellular targeting, our data shed new light on the potential function of dynactin in cytoplasmic dynein-mediated motility.
Primary Structure of the Intermediate Chains
Our current analysis of numerous additional cDNAs has indicated the existence of at least five IC isoforms in rat, apparently products of an alternative splicing mechanism involving two genes. The expression patterns of IC-1 and IC-2 were found to be very different. We note that a monoclonal anti-IC (74.1) antibody used in our earlier study (Paschal et al., 1992 ) detects both IC-1 and IC-2 (data not shown), explaining the widespread IC expression pattern observed by immunoblotting in that study.
Apparent alternative splicing was revealed at two positions within the NH2-terminal half of the cytoplasmic ICs, one of which coincides between the IC-ls and IC-2s. The pattern of alternative splicing observed for the ICs is similar to that observed for the kinesin light chains, where two sites of splicing generate at least three isoforms (Cyr et al., 1991) . This degree of IC isoform complexity suggests that different populations of cytoplasmic dynein are likely to exist in the cell, each with a different IC complement.
Interaction between Intermediate Chains and p150 Glued
The interaction of the cytoplasmic dynein ICs with p150 Gtuea was observed using both solid-phase and solution-phase assays. Unmodified and epitope-tagged versions of two IC Figure 5 . Blot overlay of recombinant p150 Gt"ea with cytoplasmic dynein ICs. Truncated recombinant p150 Gtued polypeptides consisting of residues 39-1325 (lane 1), 150-811 (lane 2), or 811-1325 (lane 3) were subjected to electrophoresis and electroblotting and incubated with recombinant IC-1A followed by anti-IC antibody (A), or recombinant IC-2B followed by anti-IC2 antiserum (B). Arrows indicate the SDS-PAGE mobility of the complete product of each expression construct. Lower molecular weight bands represent premature termination products resulting from differing codon bias between mammals and bacteria. Rat-2 cell lysate (A) and ATP-extracted microtubule samples as described in Fig. 4 (B) were incubated with an aa 150-811 p150 Glued fragment followed by anti-pl50 ct~ed (lane 1), anti-IC alone (lane 2), or anti-pl50 °l"ed alone (lane 3).
isoforms were used to test binding specificity. The interaction was detected using either the ICs or p150 Glued as the probe molecule, and its specificity was evident using complex protein samples (Figs. 4, 6, 7, and 9) .
The interaction was also specific to limited regions of both the IC and p150 Glued polypeptides (Figs. 5, 7, and 8; Table I ). We note that the binding site within the ICs for p150 clued resides near the N H 2 terminus, in a segment of the IC which includes the predicted coiled-coil domain and the serine-rich cluster. Both regions appear to be essential, in that the coiled-coil segment alone failed to recognize p150 Glued (Fig. 8) , while removal of this region was sufficient to abolish binding (Fig. 8) . The involvement of the serine cluster suggests that the IC-pl50 Gl"ed interaction might be regulated by phosphorylation. The coiled-coil domain could interact directly with the coiled-coil portion of p150 °t~ed (see below). However, it is also possible that this region is responsible for IC self-association. In this view, removal of the domain might result in dissociation of an active IC dimer into inactive IC monomers.
Our data indicate that the IC-binding domain of p150 al"ea resides between residues 200 and 811. This region includes a large predicted coiled-coil segment lying between residues ~210 and ~550, but lacks the previously identified NH2-terminal microtubule-binding and COOH-terminal Arp-l-binding domains (Waterman-Storer et al., 1995) . We conclude, therefore, that the IC-binding domain must represent a distinct functional region within the polypeptide. Conceivably, the ICs may interact with p150 alued via a coiled-coil interaction, but further work will be needed to define the interaction sites more precisely.
We also note that the original Glued mutation, Gl 1 (Plough and Ives, 1935) , is known to result from a transposon insertion causing deletion of the COOH-terminal ~300 residues (Swaroop et al., 1987) . Based on our findings, we predict that the mutant product of the GI 1 allele should retain the IC-binding domain, leading us to speculate that the defect lies in the inability of the mutant p150 Glued to interact with other dynactin components. In particular, p150 clued in GI 1 should lack the Arp-l-binding domain (Waterman-Storer et al., 1995) .
Cytoplasmic Dynein Interactions in the Cell
Dynactin was initially described as a factor capable of stimulating dynein-mediated vesicle motility in vitro Gill et al., 1991) . However, the mechanism by which stimulation occurred was unclear. Our resuits identify dynactin as a subcellular target for cytoplasmic dynein binding. Could dynactin, therefore, represent a "receptor" for cytoplasmic dynein? Dynactin has been localized to small punctate structures suggesting an organellar distribution (Gill et al., 1991; Clark and Meyer, 1992; Paschal et al., 1993) . Colocalization with cytoplasmic dynein on particular organelles has been difficult to demonstrate because of the large number of small dynein and dynactin positive structures in the interphase cell.
In vitro, efficient dynein-mediated movement of membranous organelles requires dynactin Gill et al., 1991) , consistent with the assembly of these two complexes on organelles. In addition, recent work has revealed colocalization of dynactin with cytoplasmic dynein on the kinetochores of prometaphase chromosomes (Echeverri et al., 1996) , where cytoplasmic dynein has already been detected (Pfarr et al., 1990; Steuer et al., 1990) . Therefore, these two complexes seem likely to interact directly in the cell. Whether dynactin serves as a simple receptor on kinetochores and organelles is unclear, however. Dynactin can be purified as a soluble complex, and none of the dynactin components cloned to date contain a transmembrane domain. In these regards dynactin would represent an unconventional receptor. Conceivably it serves this role in a novel fashion, perhaps as a component of a more extensive organelle surface cytoskeleton analogous to the plasma membrane skeleton of erythrocytes. It is of interest that a Golgi-specific isoform of 13- 8) anti-myc plus IC-2B-myc. p150 at"ea is often observed as a doublet (p150/ 135) in brain preparations, but is sometimes observed as a single band in cultured cell extracts. This may indicate that p150 ct"ed is subject to limited proteolysis during biochemical purification. spectrin has recently been identified (Beck et al., 1994) , which, conceivably, could participate with dynactin in construction of an organelle surface assembly.
However, such a simple model is problematic in view of the microtubule-binding activities of both cytoplasmic dynein and p150 Glued. In a supercomplex of dynein and dynactin, the static microtubule-binding activity of p150 Gt"ea would be expected to counteract the force-producing activity of cytoplasmic dynein. This apparent contradiction strongly suggests regulation of the activities of the individ-ual components of the complexes. In one view, dynactin would serve as an intermediary structure in the association of dynein with organelles and kinetochores; however, the microtubule-binding activity of p150 alaea might be regulated to allow for organelle or chromosome translocation. Alternatively, the dynein-dynactin association might occur sequentially. For example, dynactin might bind to subcellular structures first, and serve in some manner to mediate dynein binding. Dynactin would subsequently be discarded in order to allow for force production to be realized. This mechanism is reminiscent of current models for vesicle targeting and fusion, and suggests that recognition of organelles and kinetochores by motor proteins could be a complex and highly regulated process. Understanding the regulation of the dynein-dynactin interaction and the role of the remaining cytoplasmic dynein and dynactin subunits promises to provide important new insight into this process.
